Put Options

4 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q2 2022

Aug 12, 2022

SELL
$2.73 - $5.61 $7,098 - $14,586
-2,600 Reduced 17.93%
11,900 $16,000
Q4 2020

Feb 16, 2021

BUY
$5.0 - $9.15 $12,000 - $21,960
2,400 Added 19.83%
14,500 $10,000
Q3 2020

Nov 13, 2020

SELL
$3.96 - $6.15 $4,752 - $7,380
-1,200 Reduced 9.02%
12,100 $4,000
Q2 2020

Aug 10, 2020

BUY
$3.08 - $6.56 $40,964 - $87,248
13,300 New
13,300 $33,000

Others Institutions Holding CRMD

About CorMedix Inc.


  • Ticker CRMD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 41,208,200
  • Market Cap $426M
  • Description
  • CorMedix Inc., a biopharmaceutical company, focuses on developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory diseases in the United States and internationally. Its lead product candidate is DefenCath/Neutrolin, a novel anti-infective solution for the reduction and prevention of cathet...
More about CRMD
Track This Portfolio

Track Hap Trading, LLC Portfolio

Follow Hap Trading, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hap Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Hap Trading, LLC with notifications on news.